Temozolomide chronotherapy in patients with glioblastoma: A retrospective single-institute study

Authors

Anna R Damato, Washington University in St. Louis
Jingqin Luo, Washington University School of Medicine in St. Louis
Ruth G N Katumba, Washington University School of Medicine in St. Louis
Grayson R Talcott, Washington University School of Medicine in St. Louis
Joshua B Rubin, Washington University School of Medicine in St. Louis
Erik D Herzog, Washington University School of Medicine in St. Louis
Jian L Campian, Washington University School of Medicine in St. Louis

Journal

Neuro-Oncology Advances

Publication Date

1-1-2021

Volume

3

Issue

1

First Page

vdab041

Document Type

Open Access Publication

DOI

10.1093/noajnl/vdab041

Rights and Permissions

Anna R Damato, Jingqin Luo, Ruth G N Katumba, Grayson R Talcott, Joshua B Rubin, Erik D Herzog, Jian L Campian, Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study, Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab041, https://doi.org/10.1093/noajnl/vdab041. © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

Recommended Citation

Damato, Anna R; Luo, Jingqin; Katumba, Ruth G N; Talcott, Grayson R; Rubin, Joshua B; Herzog, Erik D; and Campian, Jian L, "Temozolomide chronotherapy in patients with glioblastoma: A retrospective single-institute study." Neuro-Oncology Advances. 3, 1. vdab041 (2021).
https://digitalcommons.wustl.edu/oa_4/757

Additional Links

Supplemental material is available for this article at publisher site.